Occult hepatitis B in HIV-HCV coinfected patients

References

• Chemin I, Trepo C. Clinical impact of occult HBV infections. J Clin Virol 2005; 34(Suppl 1)S15–21
   PubMed Web of Science ®Google Scholar
• Nunez M, Rios P, Pérez-Olmeda M, Soriano V. Lack of ‘occult’ hepatitis B virus infection in HIV infected patients. AIDS 2002; 16: 2099–101
   PubMed Web of Science ®Google Scholar
• Neau D, Winnock M, Jouvencel A, Faure M, Castera L, Legrand E, et al. Occult hepatitis B virus infection in HIV infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002–2003. Clin Infect Dis 2005; 40: 750–3
   PubMed Web of Science ®Google Scholar
• Rodriguez-Torres M, Gonzalez-Garcia J, Brau N, Sola R, Moreno S, Rockstroh J, et al. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) coinfection: clinically relevant or a diagnostic problem?. J Med Virol 2007; 79: 694–700
   PubMed Web of Science ®Google Scholar
• Gandhi R, Wurcel A, McGovern B, Lee H, Shopis J, Corcoran C, et al. Low prevalence of ongoing hepatitis B viraemia in HIV-positive individuals with isolated antibody to hepatitis B core antigen. J Acquir Immune Defic Syndr 2003; 34: 439–41
   PubMed Web of Science ®Google Scholar
• Pogany K, Zaaijer HL, Prins JM, Wit FW, Lange JM, Beld MG. Occult hepatitis B virus infection before and 1 y after start of HAART in HIV type-1-positive patients. AIDS Res Hum Retroviruses 2005; 21: 922–6
   PubMed Web of Science ®Google Scholar
• Quarleri J, Moretti F, Bouzas M, Laufer N, Carrillo M, Giuliano S, et al. Hepatitis B virus genotype distribution and its lamivudine-resistant mutants in HIV-co-infected patients with chronic and occult hepatitis B. AIDS Res Hum Retroviruses 2007; 23: 525–31
   PubMed Web of Science ®Google Scholar
• Santos EA, Yoshida CF, Rolla VC, Mendes JM, Vieira IF, Arabe J, et al. Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type-1. Eur J Clin Microbiol Infect Dis 2003; 22: 92–8
   PubMed Web of Science ®Google Scholar
• Shire NJ, Rouster SD, Rajicic N, Sherman KE. Occult hepatitis B in HIV-infected patients. J Acquir Immune Defic Syndr 2004; 36: 869–75
   PubMed Web of Science ®Google Scholar
• Re VL III, Frank I, Gross R, Dockter J, Linnen JM, Giachetti C, et al. Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients. J Acquir Immune Defic Syndr 2007; 44: 315–20
   PubMed Web of Science ®Google Scholar
• Drosten C, Nippraschk T, Manegold C, Miesel H, Brixner V, Roth WK, et al. Prevalence of hepatitis B virus DNA in anti-HBc-positive/HBsAg-negative sera correlates with HCV but not HIV serostatus. J Clin Virol 2004; 29: 59–68
   PubMed Web of Science ®Google Scholar
• Piroth L, Binquet C, Vergne M, Minello A, Livry C, Bour J, et al. The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients. J Hepatol 2002; 36: 681–6
   PubMed Web of Science ®Google Scholar
• Wagner A, Denis F, Weinbreck P, Loustaud V, Autofage F, Rogez S, et al. Serological pattern ‘anti-hepatitis B core alone’ in HIV or hepatitis C virus-infected patients is not fully explained by hepatitis B surface antigen mutants. AIDS 2004; 18: 569–71
   PubMed Web of Science ®Google Scholar
• Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. J Clin Virol 2006; 35: 14–20
   PubMed Web of Science ®Google Scholar
• Filippini P, Coppola N, Pisapia R, Scolastico C, Marrocco C, Zaccariello A, et al. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy. AIDS 2006; 20: 1253–60
   PubMed Web of Science ®Google Scholar
• Jilg W, Sieger E, Zachoval R, Schätzle H. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. J Hepatol 1995; 23: 14–20
   PubMed Web of Science ®Google Scholar
• Hofer M, Joller-Jemelka H, Grob P, Lüthy R, Opravil M. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Eur J Clin Microbiol Infect Dis 1998; 17: 6–13
   PubMed Web of Science ®Google Scholar
• Chemin I, Baginski I, Petit M, Zoulim F, Pichoud C, Capel F, et al. Correlation between HBV DNA detection by polymerase chain reaction and pre-S1 antigenaemia in symptomatic and asymptomatic hepatitis B virus infection. J Med Virol 1991; 33: 51–7
   PubMed Web of Science ®Google Scholar
• Wagner AA, Loustaud-Ratti V, Chemin I, Weinbreck P, Denis F, Alain S. Double hepatitis B virus infection in a patient with HIV/hepatitis C virus coinfection and ‘anti-HBc alone’ as serological pattern. Eur J Clin Microbiol Infect Dis 2005; 24: 623–7
   PubMed Web of Science ®Google Scholar
• Torres-Baranda R, Bastidas-Ramirez BE, Maldonado-Gonzalez M, Sanchez-Orozco JV, Vasquez-Vals E, Rodriguez-Noriega E, et al. Occult hepatitis B in Mexican patients with HIV, an analysis using nested polymerase chain reaction. Ann Hepatol 2006; 5: 34–40
   PubMedGoogle Scholar
• Shire NJ, Rouster SD, Stanford SD, Blackard JT, Martin CM, Fichtenbaum CJ, et al. The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. J Acquir Immune Defic Syndr 2007; 44: 309–14
   PubMed Web of Science ®Google Scholar
• Lacombe K, Massari V, Girard PM, Serfaty L, Gozlan J, Pialoux G, et al. Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV. AIDS 2006; 20: 419–27
   PubMed Web of Science ®Google Scholar